TrialCard News
PRESS RELEASE
919 MARKETING, A HIGH-TECH PR AND MARKETING FIRM TO SPEARHEAD NATIONAL MEDIA RELATIONS CAMPAIGN FOR TRIALCARD.
Raleigh, NC May 17, 2002 919 Marketing Company, a privately held Raleigh area marketing and public relations consulting firm, announced today that it has signed a services agreement with the burgeoning pharmaceutical transaction services company TrialCard Inc.
919 Marketing Company was created in 1996 by CEO David Chapman, a marketing thought leader with over 20 years of senior management experience with Fortune 500 corporations and entrepreneurial, emerging growth companies.
TrialCard’s exclusive ” IA Technology” ™ captures real time ROI sampling data from all points of contact (reps, physicians, patients, pharmacists), thus enabling pharmaceutical companies to effectively measure cause and effect relationships. Moreover, TrialCard powered programs can be activated or deactivated at any point in the sampling process.
According to Chuck Reuben, COO of TrialCard, “We are a young company with a terrific product and aggressive growth plans – and we know that market awareness drives market share. We first became aware of 919 Marketing through their work with one of our strategic partners; we saw first hand their proven ability to generate deep and sustained media coverage by national editorial and analyst communities.”
919 Marketing CEO David Chapman said, “TrialCard’s patented technology is poised to revolutionize the sampling process for pharmaceutical companies. We will play an active, on-going role in connecting this great company and its incredible value proposition with the thought leaders who reach and influence the medical decision makers who control TrialCard’s destiny.”
###
About TrialCard:
Headquartered in Raleigh, NC, TrialCard Inc. is a transaction services company specializing in implementation of marketing programs where drug distribution is involved, including product sampling, direct-to-consumer, direct-to-physician, loyalty programs, patient assistance programs and clinical trials companies.
TrialCard's patented “IA Technology” delivers prescription medication via magnetic stripe cards, similar to credit cards, which can be activated and de-activated. TrialCard provides pharmaceutical companies a vehicle to track and increase patient persistency and compliance.
For more information about TrialCard's services, please contact Chuck Reuben COO (call 919-845-0774, or email creuben@trialcard.com) or visit http://www.trialcard.com/.
About 919 Marketing:
919 Marketing is a Holly Springs, North Carolina based marketing communications company that specializes in helping emerging, fast track companies and Global 2000 corporations create and implement world-class marketing and PR programs that work.
Located just outside North Carolina’s Research Triangle Park – 919 provides companies with a refreshingly powerful alternative to both expensive, out of touch advertising agencies and number crunching, linear business consulting firms.
Since 1996, 919 Marketing has generated proven, documented success in helping dozens of technology enabled clients increase revenue, create a competitive advantage, differentiate themselves from the competition and improve sales, marketing and public relations efficiencies.
For more information, please contact David Chapman, CEO, 919 Marketing Company at 919-557-7890 or email dchapman@919marketing.com or visit www.919marketing.com.
|
|
|  | |
